The most marked increases in non-prostate-cancer mortality were among those men in the screening arm with Tumor-Node-Metastasis -stage T1c cancers at diagnosis (i.e., impalpable cancers detectable only by PSA testing [28]). This evidence concerns the gene KLK3 and prostate carcinoma.